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httcense.Abstract Background: Prior studies have shown that biomarkers of inﬂammation, including
TNF-a, are raised in patients with sleep apnea. TNF-a is one of important risk factors for athero-
sclerosis, stroke, and cardiovascular disease in OSA patients.
Aim of the study: To determine whether TNF-a blood levels are elevated in OSA syndrome and
whether they are reversible after surgical intervention.
Methods: Among the patients who had visited the ENT clinic for evaluation of sleep problems,
70 subjects were selected. Polysomnography (PSG) and morning venous blood serum for levels of
TNF- a were performed in all the subjects and 35 patients were diagnosed as having OSAS. All
patients with OSA had surgical intervention according to individual cases. Laser assisted uvulopal-
atoplasty (LAUP), extended LAUP (LAUP and laser assisted tonsillar ablation), or laser assisted
uvuloplasty were done using a CO2 laser. Sleep apnea monitoring, clinical evaluation and TNF-a
level were then compared before and 3 months after intervention.Apnea; ODI, Oxygen Desa-
y; TNF-a, Tumour Necrosis
ulopalatoplasty; CPAP, Con-
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180 E. Reyad et al.Results: We compared thirty ﬁve patients with OSA (21 males and 14 females), mean age
(46.6 ± 12.4), with 35 control subjects (11males and 24 females), mean age (34.2 ± 9.6). The mean
(SD) plasma level of TNF-a was signiﬁcantly higher in patients with OSAS than in control group
{(5.77 ± 4.04 pg/ ml vs. 2.24 ± 1.5 pg/ml respectively, (P= 0.039)}, and TNF-a level signiﬁcantly
decreased to {(3.22 ± 3.4 pg/ml) (P= 0.001)} after treatment. In addition, TNF-a levels showed a
statistically signiﬁcant positive correlation with the AHI before treatment and with neck circumfer-
ence after treatment.
Conclusion: Our results suggest that TNF may be prognostic factors for comparing patients with
OSAS before and after treatment.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Obstructive sleep apnea syndrome (OSAS) is characterized by
repeated episodes of upper airway occlusion during sleep that
is associated with excessive daytime sleepiness and abnormali-
ties in cardiopulmonary and metabolic function. Systemic
inﬂammation is a rather universal characteristic of apnea.
Studies have implicated both local and systemic inﬂammation
in the pathphysiology of syndrome.
Variations in certain immune parameters in obstructive
sleep apnea syndrome (OSAS) have been established in the last
few years, but whether these changes play a causative role or
are merely a consequence of pathogenic mechanisms underly-
ing OSAS remains to be elucidated. Prior studies have shown
that biomarkers of inﬂammation, are raised in patients with
apnea The most relevant ﬁndings in OSAS patients are in-
creased tumor necrosis factor (TNF)-a and interleukin (IL)-6
secretion from peripheral mononuclear cells stimulated with
lipopolysaccharide, as well as the increase in plasma levels of
these two proinﬂammatory cytokines compared with control
subjects. Their levels appeared signiﬁcantly correlated with
the percentage of time of apnea and hypopnea, as well as the
percentage of time spent at SaO2 below 90% during the total
sleep period [1].
Tumor necrosis factor (TNF)-a and interleukin-6 levels are
elevated in patients with OSAS when compared with patients
with hypersomnia [2] and subjects with nonapneic obesity.
[3] Importantly, the circadian rhythm of TNF-a secretion in
patients with OSAS is markedly different compared with
healthy volunteers [4].
Application of nasal continuous positive airway pressure
(CPAP) for 3 months does not change the abnormal circadian
pattern, implying a role for inﬂammation independent of
mechanical obstruction in pathogenesis of obstructive sleep ap-
nea. Given that TNF-a is thought to modulate somnolence and
fatigue, this cytokine may play a role in mediating the constitu-
tional symptoms of obstructive sleep apnea [4].
On the other hand, it has been reported that TNF-a levels are
increased in pediatricOSA, driven primarily by sleep fragmenta-
tion and bodymass index, and are closely associatedwith the de-
gree of sleepiness. The study also showed that surgical treatment
of OSA (a standard treatment for the disorder in children) re-
sulted in signiﬁcant reductions in TNF-a levels with reciprocal
prolongations in sleep latency [5].
The present study was designed to evaluate the plasma level
of TNF-a in patients with OSAS and determine the effect of
surgical treatment on TNF-a level.Study Design and Subjects
The study included 70 adult patients of age P18 years among
those who had visited chest or otolaryngology clinic for evalu-
ation of sleep problems in Suez Canal University Hospital
from June, 2006 to June, 2010. Polysomnography (PSG) was
performed in all the patients, and 35 patients were diagnosed
as having OSAS (OSAS group) and 35 patients without OSAS
(control group). We deﬁned OSAS as cases in which AHIP 5/
hour, and controls had an AHI < 5.
Demographic data, and clinical assessment including BMI,
neck circumference (NC), ENT examination, measurement of
blood pressure, and assessment of the Epworth sleepiness scale
(ESS) to assess daytime sleepiness were conducted on all the
study population., in addition to sleep apnea monitoring
parameters, co morbidities, and TNF-a levels were recorded
and compared in both groups.
Exclusion criteria for patients and for control subjects were
as follows: (1) symptoms or signs of acute or chronic inﬂam-
mation (2) use of corticosteroids or antibiotics for the 4 weeks
preceding recruitment in the study, (3) hypertension or CVD,
(4) neuromuscular or genetic disorders, (5) history of smoking,
chronic pulmonary disease, and (6) diabetes and metabolic
disorders.
Polysomnography
Baseline sleep apnea monitoring was done, using the polysom-
nogram {(SAM equipment), Intercare technologies, model
100}. It was followed up 3 months after intervention. The pres-
ence and severity of sleep apnea were determined by standard
overnight polysomnography, including electroencephalogra-
phy (EEG), electrooculography (EOG), electromyography
(EMG), oximetry, thermistor measurements of airﬂow, and
measurements of rib cage and abdominal movements when
breathing. An apnea was deﬁned as complete cessation of air-
ﬂow for at least 10 s. Hypopnea was deﬁned as P50% reduc-
tion of respiratory signals for at least 10 seconds associated
with oxygen desaturation of P4%. Central, obstructive and
mixed apneic events were counted. Obstructive apnea was de-
ﬁned as the absence of airﬂow with continued chest wall and
abdominal movement for duration of at least 10 s. The AHI
was calculated as the total number of respiratory events per
hour of sleep. Additional sleep parameters derived from poly-
somnography included Desaturation Index, Lowest SO2%,
Mean SO2%, and Percent Sleep Time spent with SO2 values
<90%, were evaluated.We deﬁnedOSAS and classiﬁed as mild
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AHI of 30 or more.
Level of TNF-a
Venous blood samples were withdrawn between 6 and 7 am
for TNF-a in the morning following the sleep study, at base-
line and 3 month after intervention. They were kept in 80 c
till time of measuring. TNF-a, was measured using the
Immulite equipment. Normal level of TNF-a was less than
4 pg/ml.
Surgical intervention
Surgical intervention was selected according to individual cases.
Laser assisted uvulopalatoplasty (LAUP), extended LAUP
(LAUP and laser assisted tonsillar ablation), or laser assisted
uvuloplasty were done using a CO2 laser.
All patients had one session that was about 20 to 30 min
each.
Informed consent was obtained from all participants, and
our institutional review board approved this study.
Statistical analysis
Statistical analysis was carried out using SPSS version 12.0
software program (SPSS Inc, Chicago, Illinois). Data were pre-
sented using descriptive statistics in the form of frequencies
and percentages for qualitative variables, and means and stan-
dard deviations for quantitative variables. Quantitative contin-
uous data were compared using student – t – test in case of
comparisons between two groups, and paired t – test in case
of comparison between pre – and post – intervention in the pa-
tient group. When normal distribution of the data could not be
assumed, Mann–Whitney and Wilcoxon tests were used in-
stead of student –t– test. Qualitative variables were compared
using chi–square test. To identify the independent factors of
TNF-a, AHI, lowest oxygen saturation, backward stepwise
regression analysis was used. Statistical signiﬁcance was con-
sidered at p-value <0.05 and bivariates correlation test was
used to determine the relation between each cytokine and sleep
apnea parameters. A coefﬁcient of correlation was obtained
with the same program. Statistical signiﬁcance was set at a P
value of .01.
Outcome measures
Improvement of the AHI, lowest oxygen saturation, and oxy-
gen desaturation index, and improvement of TNF-a levels
after surgical intervention.
Results
Baseline characteristics of the study groups are described in the
(Table 1).
Thirty ﬁve (21 male and 14 female) patients with OSA were
analyzed. The mean age was (46.6 ± 12.4) years. The normal
control group consisted of 35 (11 male and 24 female) patients
with normal ﬁndings on PSG, mean age was (34.2 ± 9.6),
(P= 0.000).In patientswithOSA,meanAHIwas 24.57 ± 15.9 events/h vs.
1.60 ± 0.61 events/h in control group (P= 0.000). The mean
(SD) BMI of the normal control, and OSAS groups were
31.2(5.62), and 35 (7.9) respectively (P= 0.00). In OSA group;
desaturation index was 24.6 ± 22.8 vs. 5.5± 5.8 in control group
(P= 0.000), Mean SO2% was 83 ± 6% vs. 94± 1.2 in control
group (P= 0.000)% total time slept in <90% was 16 ± 5 vs.
0.12 ± 0.8 in control group (P= 0.000), and the lowest oxygen le-
vel during sleep averaged 71.8 ± 12.3% vs. 84.5 ± 8.8 in control
group (P= 0.000).
(Table 2) Shows comparison of AHI, lowest O2, ODI, NC,
and BMI as indices of OSA, pre and post surgical intervention
in OSA group, and it conﬁrmed statistically signiﬁcant
improvements in all indices except for NC.
TNF-a Levels
Comparison of the mean (SD) plasma level of TNF-a, between
sleep apnea patients and controls is shown in (Table 1). Also le-
vel of TNF-a (both before and after surgical intervention) is
shown in (Table 3). PlasmaTNF-a levels were signiﬁcantly high-
er in patients with OSA than in controls {(5.77 ± 4.04 pg/ml vs.
2.24 ± 1.5 pg/ ml respectively, (P= 0.039)} (Table 1); and
TNF-a level signiﬁcantly decreased to {(3.22 ± 3.4 pg/ml)
(P= 0.001)} after treatment (Table 3).
Backward stepwise regression for TNF-a levels and various
factors affecting it as independent factors in both groups of the
study population; The plasma levels of TNF-a measured before
surgical intervention in obstructive sleep apnea group showed no
signiﬁcant correlation with age, sex, BMI, neck circumference,
ENT examination ﬁndings, Epworth score, and oxygen desatura-
tion index. There was a statistically signiﬁcant positive correla-
tion between the TNF-a levels and AHI (Table 4).
Regression analysis for TNF levels after surgical interven-
tion and various factors affecting it as independent factors
among OSA patients, showed no signiﬁcant correlation with
age, sex, BMI, ENT examination ﬁndings, Epworth score,
AHI and oxygen desaturation index. There was a statistically
signiﬁcant positive correlation between the TNF-a levels and
neck circumference (Table 5).
Discussion
The recurrent obstructive events with cyclic intermittent apne-
as (CIA) and sleep fragmentation are believed to be the key
triggers of various pathogenetic mechanisms in OSA, including
sympathetic activation, cellular oxidative stress and systemic
inﬂammation. Intermittent apneas followed by reoxygenation
may result in increased oxidative stress, in addition to selective
up regulation of inﬂammatory pathology over adaptive path-
ways, to generate cytokines and other mediators that modulate
metabolic and vascular functions [1].
Studies have implicated local and systemic inﬂammation in
the pathophysiology of this seemingly all-mechanical problem.
Histological analysis of tissues obtained from patients under-
going uvulopalatopharyngoplasty for obstructive sleep apnea
reveals marked subepithelial edema, excessive plasma cell inﬁl-
tration, and reduction in surface area of connective tissue
papillae that provide anchorage for epithelium [6]. In the nasal
lavage ﬂuid of patients with obstructive sleep apnea, polymor-
phonuclear leukocytes and concentrations of bradykinin and
Table 1 Baseline characteristics and sleep proﬁles in OSA patients and control.
Variable Patients With OSA(n= 35) Controls (n= 35) P
Sex, M:F 21:14 11:24 0.02
Age, y 46.6 ± 12.4 34.2 ± 9.6 0.00
BMI, kg/m2 35 ± 7.9 31.2 ± 5.62 0.00
Neck circumference 40.7 ± 3.22 36.8 ± 2.7 0.02
AHI, events/h 24.57 ± 15.9 1.60 ± 1.61 0.000
Desaturation index 24.6 ± 22.8 5.5 ± 5.8 0.000
Lowest SO2% 71.8 ± 12.3 84.5 ± 8.8 0.000
Mean SO2% 83 ± 6 94 ± 1.2 0.000
%total time slept in<90% 16 ± 5 0.12 ± 0.8 0.000
TNF-alpha 5.77 ± 4.04 2.24 ± 1.5 0.000
Values are mean ± SD, Signiﬁcance <0.05 level.
Table 2 Comparison of BMI, NC, AHI, O2, ODI as indices of OSA, pre and post surgical intervention in OSA group.
Variable Pre mean ± SD Post mean ± SD Sig. test P-value
AHI 23.97 ± 15.8 11.5 ± 37.92 0.00
lowest o2 72.15 ± 12.3 83.2 ± 28 0.002
ODI 23.4 ± 21.7 19.24 ± 39 0.00
Neck circumference 40.66 ± 3.22 40.37 ± 3.26 0.31
BMI 35 ± 7.86 34.11 ± 7.42 0.004
Table 3 The difference between pre and post intervention
levels of TNF in OSA group.
Variable Pre mean ± SD Post mean ± SD P-value
TNF 5.85 ± 4.05 3.22 ± 3.4 0.001*
* Signiﬁcant at 95% level of conﬁdence.
Table 4 Regression analysis for TNF levels and various
factors affecting it as independent factors in both groups under
the study.
Variable Beta Std error of beta t P-value
Constant 0.44 9.01 0.00
AHI 0.40 0.21 3.61 0.00*
Model ANOVA.
Value 13.04.
R2 = .16.
Excluded variables: age, sex, BMI, neck circumference, ENT
examination ﬁndings, Epworth score, and oxygen desaturation
index.
* statistical signiﬁcance P< 0.001.
Table 5 Regression analysis for TNF levels after surgical
intervention and various factors affecting it as independent
factors among OSA patients.
Variable Beta Std error of beta t P value
Constant 7.06 1.5 0.14
Neck Circumference 0.33 0.18 1.96 0.048*
Model ANOVA.
Value 3.9.
R2 = .20.
Excluded variables: age, sex, BMI, ENT examination ﬁndings,
Epworth score, AHI and oxygen desaturation index.
* Statistical signiﬁcance P< 0.05.
182 E. Reyad et al.vasoactive intestinal peptide are increased. These inﬂamma-
tory changes are postulated to occur, in part, due to snoring
that evokes vibration frequencies associated with soft-tissue
damage, local inﬂammation, in addition to evidence of sys-
temic inﬂammation in patients with OSAS [7].
TNF-a is a powerful cytokine of inﬂammation and can be
produced by a variety of cell types, including macrophages
and monocytes. Although TNF-a has a central role in the in-
nate immune system for protection against infections, whenproduced in excess, TNF-a may also orchestrate chronic
inﬂammatory responses that lead to severe tissue damage.
The production of TNF-a is attributed to OSA- induced
hypoxic stress, and is mediated by NF-kb activation [8]. The
prevailing Th1-type cytokine pattern of the immune cells in
the peripheral blood of OSAS patients can partially be ex-
plained by hypoxia. Experimental evidence supports, in fact,
the role of hypoxia in inducing the expression of the proinﬂam-
matory cytokines, in particular TNF-a but also IL-1b and IL-6
[9]. This has clearly been delineated in in-vitro studies involv-
ing peripheral blood mononuclear cells, human macrophage
lines and alveolar macrophages stimulated with LPS, and
may be mediated by the induction of haem-oxygenase and
NF-kB activation [9].
Nevertheless, few studies have been carried out on the inﬂu-
ence of systemic hypoxemia on the production of proinﬂam-
matory cytokines [10]. The activation of the TNF-a system
has been clearly shown in chronic obstructive pulmonary dis-
ease, a condition characterized by chronic hypoxemia; how-
ever, the effect of brief but repeated hypoxemic conditions,
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poorly known. It can be hypothesized that short-lasting but
recurrent hypoxemic episodes and reactive oxygen species in
OSAS patients can increase the production of proinﬂamma-
tory cytokines by mononuclear cells, as suggested by experi-
mental evidence. This may be responsible for the rise in their
peripheral blood levels, as a result of their spill-over into the-
from these cells [11].
In Alberti et al. study [1] they determined the plasma levels
of the proinﬂammatory cytokines IL-1, TNF-a, and IL-6, and
of the anti-inﬂammatory cytokines IL-10 and transforming
growth factor (TGF)-b before beginning nocturnal polysom-
nography, and immediately after the ﬁrst obstructive apnea
causing an SaO2 <85%. They observed an increase in the plas-
ma levels of the proinﬂammatory cytokines TNF-a, and to a
lesser extent IL6, in a small group of OSAS patients assessed
at bedtime (22:00 hours) before polysomnographic recording.
After the ﬁrst obstructive apnea causing a desaturation below
85%, a signiﬁcant further increase in the levels of TNF-a was
found, with no variations in the plasma levels of the other
cytokines.
In our study, TNF-a increased in OSA patients and TNF-a
level showed a statistically positive correlation with severity of
OSA (measured by the AHI). Contrary to previous literature,
we found no correlation between lowest oxygen desaturation,
oxygen desaturation index and the high levels of cytokines.
In contrast to our ﬁndings, Ulukavak et al. [12] found a posi-
tive relationship between TNF- a and the AHI and hypox-
emia, which reﬂect the severity of OSA. However, differences
in cytokine levels between severe-moderate OSAS and mild
OSAS patients cannot be excluded. It can be hypothesized that
beyond certain values of lower mean values of O2 saturation, a
linear correlation cannot be found, suggesting that additional
unknown mechanisms other than hypoxia may be involved
in inducing higher levels of proinﬂammatory cytokines in
OSAS patients.
Experimental evidence shows that total and partial sleep
deprivation primes immune cells to produce higher levels of
proinﬂammatory cytokines when stimulated in vitro. One
night of 3.5 hr of sleep was associated with a signiﬁcant in-
crease in monocyte-derived production of IL-1B and TNF-a.
Thus, it has been proposed that early pro-inﬂammatory re-
sponses may provide a physiologic mechanism linking sleep
disruption to risk of inﬂammatory disease [13].
The central role played by TNF-a in modulating sleep has
been clearly elucidated [14]. There is evidence in experimental
animals that systemic TNF-a enhances sleep in animals, and
conversely, that inhibition of this cytokine suppresses sleep
[15]. A recent report documented a marked decrease in sleep-
iness in OSA patients given etanercept, a medication that
neutralizes TNF-a [16], Based on the above ﬁndings, it can
be hypothesized that increased levels of TNF-a in our OSAS
patients contributed to sleep apnea. By inducing sleepiness,
which is associated with more apnea, increased levels of
TNF-a would establish a vicious cycle in the pathogenic
events of OSAS.
Many studies showed results consistent with our result,
[17] and reported that TNF-a was elevated in experimentally
induced sleepiness in healthy young adults after one or sev-
eral nights of total loss, or partial sleep loss for one week.
Other studies found that Tumor necrosis factor (TNF)-a
was elevated in patients with OSAS when compared withpatients with hypersomnia and subjects with nonapneic
obesity [3].
In this current study, we found no correlation between the
high levels of TNF-a and both of BMI, and neck circumfer-
ence, this observation is in agreement with report of Ulukavak
et al. [12] who found that TNF-a was elevated in OSA and
compounded with, but independent of obesity.
According to Vgontzas et al. [2,3] the increase in TNF-a
and IL-6 levels was common to disorders characterized by
excessive daytime sleepiness, and therefore can be detected
not only in OSAS but also in narcolepsy and idiopathic hyper-
somnia. Variations in IL-6 and TNF-a in OSAS patients ap-
peared to be associated with daytime sleepiness and fatigue
and their increase appeared to be strongly and independently
correlated with insulin resistance and visceral obesity. [3] As
in previous research, visceral fat was not measured in our
study, and thus no correlation with cytokine levels could be
obtained. however, we found positive correlation between
the levels of TNF-a and NC post surgery in interventional
group.
Guasti et al. [18] reported marked production of TNF-a
from peripheral blood monocytes of severe OSA patients com-
pared to controls who are free from confounding factors such
as diabetes, hypertension and ischemic heart disease. Also
TNF-a production has been increased compared to healthy
controls, obese controls and mild OSA patients.
The study of Lecube et al. [19] evaluated the level of soluble
TNF receptor 1 in non-diabetic obese women (their BMI was
48.1 ± 6.1 kg/m2). Soluble TNF receptor 1 level reﬂects TNF-
a level, and it is mainly expressed on epithelial lung cells,
whereas soluble TNF–receptor-2 is primarily expressed on
the cell surface of myeloid origin. They found a statistically
signiﬁcant negative correlation between soluble TNF receptor
1 and FEV1 and FVC, as well as with the maximum mid expi-
ratory ﬂow. This study highlights the role of TNF-a as an early
indicator of the impact of systemic inﬂammation in morbidly
obese patients
The cytokine that seems more sensitive to rapid changes in
O2 saturation is TNF-a, although the role of its ﬂuctuations in
the pathogenic events of OSAS remains to be elucidated.
Bhushan et al. [20] demonstrated that obese OSA Asian
Indians had signiﬁcantly higher frequency of TNF-a (308
A) allele than (308 G) allele and that TNF-a levels correlated
with severity of OSA and decreased oxygen desaturation. This
suggest that TNF-a (308 A) allele may be a risk factor for
OSA, and that TNF-a (308 A) allele may increase the suscep-
tibility to symptoms (somnolence and fatigue) and exacerba-
tion of upper airways inﬂammation. [21] It has been reported
that patients who has poorer sleep quality has greater levels
of TNF-a, IL-1b, and IL-6, and that fatigue is related to higher
BMI and to increased soluble TNF receptor 1. [13]
We have found that, after surgical intervention, patients
who had higher neck circumference were expected to have
higher levels of TNF-a. This may conﬁrm the importance of
losing weight, even when other modalities of treatment are per-
formed. This also emphasizes that treatment of OSA should be
global with emphasis on contributing factors such as reducing
weight and correcting the anatomy of the upper airway.
Our study agrees with the study of Paschalis et al. [22] who
found a signiﬁcant elevation of TNF levels in OSA patients
that reduced after 6 months of CPAP treatment, for at least
4 hours per night. The same for our intervention group in
184 E. Reyad et al.our study showed marked improvement after surgical interven-
tion including LAUP, extended LAUP and uvuloplasty. TNF-
a levels, AHI, lowest oxygen saturation, oxygen desaturation
index, neck circumference and BMI all showed a statistically
signiﬁcant improvement.
In the same context, several investigators have also demon-
strated that TNF-a levels signiﬁcantly decrease after
treatment. Constantinos et al. [23] found that surgical
treatment of OSA resulted in a signiﬁcant reduction of the
TNF-a and IL-6 values. This has been accompanied by a sig-
niﬁcantly decreased AHI postoperatively. In addition, there
was a strong correlation between AHI changes and cytokine
plasma level changes. Tamaki et al. [8] has been demonstrated
that in severe OSA, the production of TNF-a has been
signiﬁcantly increased after sleep in the early morning, and de-
creased after long-term CPAP treatment. In addition, the
production of TNF-a by monocytes is signiﬁcantly correlated
with the severity of OSA.
The current study differs from the study of Constantinos et
al. [23] who assessed the levels of TNF-a and IL-6 in patients
who had mild to moderate OSA and had surgical intervention
and 6 months post-operative. They found that base line TNF-a
level has been correlated with BMI rather than with the sever-
ity of OSA and that level of TNF-a signiﬁcantly improved and
the improvement was correlated with decreased AHI. Their
study was conducted on mild to moderate OSA, also younger
than 55 years. The difference in their study population may
explain the different results.
The circadian rhythmof TNF-a has been demonstrated to be
disturbed in OSAS patients, but this aspect was not investigated
in our research. In a study carried out in healthy controls and
HIV patients Darko et al. [24] observed a cyclic nocturnal vari-
ation inTNF-a levels in six of 10 subjects studied, and a coupling
between the increase in TNF-a levels and sleep EEG delta spec-
tral amplitude. This ﬁnding suggests that cyclic nocturnal varia-
tions of TNF-a should be assessed in OSAS not only in relation
to the time of night but also to power spectral analyses of the
EEG.. Circadian variations in IL-1, IL-6, interferon (IFN)-c
and TNF-awere also investigated ex vivo by the short-term cul-
ture of blood samples from OSAS patients. Whereas circadian
rhythms of IL-1, IL-6, and IFN-c, and of the immunoregulatory
hormones cortisol and melatonin did not differ from those in
controls, the circadian rhythm of TNF-a was profoundly dis-
turbed. The nocturnal physiologic peaks in this cytokine almost
disappeared, and an additional daytime peak developed. More-
over, nasal continuous positive airway pressure (nCPAP) ther-
apy did not normalize TNF-a rhythms, implying a role for
inﬂammation independent of mechanical obstruction in patho-
genesis of obstructive sleep apnea.Conclusion
Our ﬁnding of increased plasma levels of TNF in OSAS pa-
tients conﬁrms previous observations of an enhanced produc-
tion of this cytokine by stimulated mononuclear cells, These
ﬁndings support a systemic activation of the inﬂammatory re-
sponse in OSAS patients. Although levels of TNF appear to be
associated with OSAS severity indicated by AHI, we did not
ﬁnd any correlation between the level of this cytokine and
ODI in addition to Epworth score, BMI, NC, and ENT exam-ination ﬁndings so these variables were not predictors for
TNF-a levels.
Moreover, the marked improvement of TNF levels after
surgical intervention suggest that TNF can be prognostic fac-
tor for comparing patients with OSAS before and after treat-
ment. Additionally, given that TNF-a is thought to
modulate somnolence and fatigue, this cytokine may play a
role in mediating the constitutional symptoms of obstructive
sleep apnea. Thus, many aspects need to be investigated in
future research, along with serial analysis of the soluble
TNF-a receptor.References
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